Please use this identifier to cite or link to this item:
http://repositorio.ufla.br/jspui/handle/1/41246| metadata.artigo.dc.title: | Pandemic preparedness: developing vaccines and therapeutic antibodies for COVID-19 |
| metadata.artigo.dc.creator: | Sempowski, Gregory D. Saunders, Kevin O. Acharya, Priyamvada Wiehe, Kevin J. Haynes, Barton F. |
| metadata.artigo.dc.subject: | COVID-19 - Vaccine Monoclonal antibodies (mAb) |
| metadata.artigo.dc.publisher: | Elsevier |
| metadata.artigo.dc.date.issued: | 2020 |
| metadata.artigo.dc.identifier.citation: | SEMPOWSKI, G. D. et al. Pandemic preparedness: developing vaccines and therapeutic antibodies for COVID-19. Cell, [S.l.], 2020. No prelo. |
| metadata.artigo.dc.description.abstract: | The SARS-CoV-2 pandemic that causes COVID-19 respiratory syndrome has caused global public health and economic crises necessitating rapid development of vaccines and therapeutic countermeasures. The world-wide response to the COVID-19 pandemic has been unprecedented with government, academic and private partnerships working together to rapidly develop vaccine and antibody countermeasures. Many of the technologies being used are derived from prior government-academic partnerships for response to other emerging infections. |
| metadata.artigo.dc.identifier.uri: | http://www.sciencedirect.com/science/article/pii/S0092867420306747 http://repositorio.ufla.br/jspui/handle/1/41246 |
| metadata.artigo.dc.language: | en_US |
| Appears in Collections: | FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19) |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.